China · Delayed Price · Currency is CNY Beijing Kawin Technology Share-Holding Company Description
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally.
The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis.
It is also involved in contract manufacture organization/contract development and manufacturing organization; technology and biotechnology development and consulting; technology promotion and application; and wholesale of pharmaceutical.
Beijing Kawin Technology Share-Holding Co., Ltd. was incorporated in 2008 and is based in Beijing, China.
| Country | China |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 601 |
| CEO | Desheng Zhou |
Contact Details
Address: Building 3, No. 6, Rongjing East Street Beijing, 100176 China | |
| Phone | 86 10 8712 0888 |
| Website | kawin.com.cn |
Stock Details
| Ticker Symbol | 688687 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000054C3 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Desheng Zhou | President and Chairman of the Board |
| Hong Juan Liu | Chief Financial Officer |
| Zhan Wang | Vice President, Board Secretary and Chief Human Resources Officer |
| Huan Wang | Executive Vice President and Director |
| Jifeng Shi | Vice President, Chief Research Officer, Core Technical Personnel and Director |
| Zhenqiang Du | Vice President |
| Jian Tang | Vice President |
| Xiao Xu | Vice President |
| Xiao Qing Li | Accounting Supervisor |
| Shan Liu | Head of Antibody Drug Development Department and Core Technical Personnel |